BLCO
Bausch + Lomb Corp
NYSE: BLCO · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$15.34
-2.42% today
Updated 2026-04-29
Market cap
$5.47B
P/E ratio
—
P/S ratio
1.07x
EPS (TTM)
$-0.62
Dividend yield
—
52W range
$11 – $19
Volume
0.4M
Bausch + Lomb Corp (BLCO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-7.06%
Operating margin
11.30%
ROE
-5.39%
ROA
0.86%
Debt/equity
0.83x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $3.67B | $710.00M | 64.17% | 11.35% | 19.37% |
| 2019 | $3.78B | $298.00M | 64.88% | 10.48% | 7.89% |
| 2020 | $3.41B | $-18.00M | 62.34% | 7.62% | -0.53% |
| 2021 | $3.77B | $182.00M | 61.04% | 8.74% | 4.83% |
| 2022 | $3.77B | $6.00M | 59.69% | 5.49% | 0.16% |
| 2023 | $4.15B | $-260.00M | 60.40% | 3.14% | -6.27% |
| 2024 | $4.79B | $-317.00M | 60.93% | 3.38% | -6.62% |
| 2025 | $5.10B | $-360.00M | 58.71% | 3.12% | -7.06% |